Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes.
Saved in:
| Title: | Endometrial Cancer by ERBB2 Amplification (ERBB2amp) Status: Differences in Molecular Subtypes, Ancestry, and Real-World Outcomes. |
|---|---|
| Authors: | Cantillo E; Weill Cornell Medicine, New York, NY., Podder V; Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Miami Beach, FL., Danziger N; Foundation Medicine, Inc, Boston, MA., Lobo D; University of Cincinnati Cancer Center, Cincinnati, OH., Lin DI; Foundation Medicine, Inc, Boston, MA., Graf RP; Foundation Medicine, Inc, Boston, MA., Coleman RL; US Oncology Research, The Woodlands, TX., Pothuri B; New York University Langone Health, New York, NY., Eskander RN; University of California San Diego, Rebecca and John Moores Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, San Diego, CA., Herzog TJ; University of Cincinnati Cancer Center, Cincinnati, OH., Slomovitz BM; Mount Sinai Medical Center, Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, Miami Beach, FL. |
| Source: | JCO precision oncology [JCO Precis Oncol] 2026 Jul; Vol. 10 (7), pp. e2501157. Date of Electronic Publication: 2026 Jul 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
